ISEQ Overall could have upside scope

Price at time of writing – 4277.

It is many years since I've written an update on Ireland's benchmark index, the ISEQ Overall.

It is longer still since I annoyed my many Irish friends by calling a major high on their stock market in February 2007, accompanied by a strong sell recommendation at 9631. Today I take a look at the ISEQ Overall again, and determine whether the recent progress towards recovery has further to go.

For the purposes of today's analysis, I will look at the chart from the major low in March 2009, ignoring all the lead-up analysis to the great unravelling of the Irish economy and accompanying destruction of its share index. The initial rally from this low faltered following a rise of 83.33%, at a level of 3446. This is an unusual Gann-theory percentage, being a combination of both a 'quarters' and 'thirds' rhythm, ie (66.66% + 100%) x 50%. After hitting 3446 in September 2009, the index then entered a period of correction, before again re-testing this level in April 2010. There followed a long period of sideways trade with a negative bias, supported in turn by its G4 and G3 levels. It was not until November 2011 that a break above the G4 line gained traction, with the index going on to complete a rise of 33.33%.

Most importantly, in January this year the Overall broke above 3446, allowing me to double that initial rise of 83.33% to one of 166.66%. The line representing this 166.66% projection aligns perfectly with the G1 level at 5014, and becomes my ultimate target as a result. Further support to this level comes courtesy of a 100% projection from the secondary low in November 2011. The 730-point rise in the index required to achieve this level leaves upside scope of around 17%.

Recommendation: buy. Target 5014. A small area of resistance lies waiting in a band defined as 4730-4768. Traders may look to book profits at this level and await a lower entry point. Stop-losses may be applied on weakness beneath 3970.

ISEQ Overall chart

 

No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. The research does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

CFD’s zijn complexe instrumenten en brengen vanwege het hefboomeffect een hoog risico mee van snel oplopende verliezen. 79% van de retailbeleggers lijdt verlies op de handel in CFD’s met deze aanbieder.
Het is belangrijk dat u goed begrijpt hoe CFD's werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
CFD’s zijn complexe instrumenten en brengen vanwege het hefboomeffect een hoog risico mee van snel oplopende verliezen.